Study of Rituximab and Brentuximab Vedotin for Relapsed Classical Hodgkin Lymphoma
Clinical trial NCT01900496 · TERMINATED
Trial details
- NCT number
- NCT01900496
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2017-07-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.